{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"familial-partial-lipodystrophy-dunnigan-type","columns":[{"gene":"","key":"population-566da43eb690a6ae134e","label":"Lipodystrophy, familial partial, type 2","mondoId":"MONDO:0007906","onsetQualifier":null,"originColumnKey":"MONDO:0007906/OMIM:151660","originalViews":[{"key":"MONDO:0007906/OMIM:151660","label":"Lipodystrophy, familial partial, type 2","scopeLabel":"OMIM:151660","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["022c5452e62cf0d6c4141efc6c772d109f92078f10481bf271db902aa877716f","034bd43e82d58b524bb95de231e735c5a1d92be8862ce66c88dedfdb30842721","07baaee4dff30391fa40f4082da4fbb278ae4a46411c87f975f17d2c6b7e1fbb","0a9dc38a6579ca2678e3224f1d9f04f217b48867a2c795524de7e74feec5a964","0ab0a4a6aebaf9bb66f734afa5f5e15502e1e464a2a46ced53b72bc188d0c299","11df62bf6c1af9176ccb56482a42e3f759aa067fe426985d6f8a5dbddd3b023d","1602c99bd01e224b65b63c0b83a3e35992574b33d3a811146a67564dcb45ea74","1737cd8e2e37f5ea3ab8ccf44854b1fbd68ae0979979285af683b86bd2042672","18a15951c99e8d83592e9078f8537e0891fc9c22776b85789f5251fc0094f583","1e606f29c6ae8d436fee98f195b40ab2a8ce938a112c306d0302280654a7653d","1f33a768e1a6672142d81fd254d411bb62507165e55b90f2cb5c11fb58de8d5a","1f74cbf217d9ec5a667a760cb443cfa8d3ba0d4e056047af3b65e5054fc2a9fb","2119121586ec867b5e8912c21e3ab2c67c5ae4c7494f7a719b30ce1501a4516b","247a53904a005caf283e1dd2867ed091c25d4075951dd43e04368cde62306753","25134b1d6c8c10353badf7f269cb8552e25900b9c79d52d5d316cb3ab00b3885","27f483ccada249fb34b9f0cab64178588c98e670a6bf91f3778da5be14f274fc","293558c9f4953aaf6a7b06484b0406763dc12a1777aae24fed32c0017d5d19f3","2ae4b79bc4eba97dc6fc7728f5eac69f124e86bcaa12cf72fafe89404dc7dac4","2b391efffd1e84b2407a392d447db7c7e34455b23261be402df4285db81a6da2","2d9421db7a874ba6cf9cea30ac1642ddbf83fb275c41847f08d36fa3fc1cce38","2de76532d475929f6836fcdf34b1216c76658bd96952f0574308cf26b3c05b23","2df6cfe61cc5ed12ebb0991e18687da6b5a8a6def020c6061a7296f86a6d69fd","2edb5222e43e5ea459ef80e5f67b31c4a5fa387b9ebe187abad3c94615132b06","33c453ef6387432fb7336543ebd2e4d1dcf2176776c72768c4ad462cb7749d0e","3af887ba84ea931f890568234cb083b3b0d23263faf03a811eef9012d6f1b812","3cc8c84c04bfb7977caa93c2fc9eb0e018221039ef5bdc1e19c51189fa063262","3f1d04cded8423a50a6bdb138dcb636ffa785f120921a2a1c4d0b0112cf52796","3fce67dd415318de1d91a07f854c5e806ca3b8c0bca2f3a691ee4d1019b01f84","451aa8f813298bbfcb6d5aefcd350fe3293d43a8fd969a0ba0d9ba62300be338","4b52270734efff69002c81feed91074ad8426c5574e40ce142db69cf54b5c5a6","556f48a1bd8b693a85f7fe4ac29778e7b465386cc7b6847883b2525168b57b35","563bc60871e5a262ad7fb06805a027fce8e5ac7122aae5fd96f1ccde2f0151ea","57bd1880e55496d2583237d872a592c7bca784ab4a6ae87dded226251f625ee7","58252a52ff0f352fe2cb079bfe52f0d9b2c7f56826ff979d858f1eb17c648082","58c95f3d63d335e4d955e82bda995625140088bf9eb89e85ae320c4145039b56","605f9079ae4a311ebb8c79d4281049372eef9d547aec9693cadf15d3deb79a5b","618bd33ca3f2ffb94e4e74854ecfd86adb31ee2700e827fc9981ba48050fee15","650fe688b0051f4850263ceafa8600e390fe4165b28f2c103db00cea62ad1395","69e2ad7cc522c758abf49e6a5b6d6398a4f70f5843525107662a42cc8f51049b","713de590eb24f07c77b45c6e6cddc3b6f65988a3b6d98ca88dd239a91c19250d","72acb0026cc6c8606eb36eb3f7d799d3d8c08a8fe0c964e36ce55a09baa428da","79c56079c976fef2ed2d5c31ccde44432690727feba6747b23b437140c234ce8","7a21bed4dbfea8debb136c53b814811bce95f7d16da5cb211210f20b8b4e4723","84893d80c37bc21207941223d6e8d6c0471c09de79b8d04c080d2251ad2d5daa","87ee8ee2506f4825fc7314d88dddd2daf8667269f3866c114094d73064308746","93abe455de59d1dc7b81389841c1ef1e602766d36354dee7e93af4b036a51b37","93ddb12f5e464f01b0428e1f3c9ab921db2f4758562fe96e0063f8c477593ca3","9467b546bc3b6ff69306a0dc3701a9140b6071288f038fffb95768c00f6a0737","94e0e542b1239cacae6c5f306fd8f5340845c6a3285960e4ce39b3ecf067323e","96c0ff4ec554b5995acc9db4f01f8980c60b38c326e7d8458c46a817430271fa","9927fd9c0d8de653fcf80927f0fd68556e4a3f091ae84426508d4f1da6c4b505","9a61e4e3d0af9e3a4699839ccb8c0e47abd1ccffc3d22f97606846f667a2137c","9b8129da136729144b6cc561656db17c69c2fb6f3b2d88ad3f61b1c3f969fedc","9bef9c42a749512d43546540fb98f61fed193af54a8e9c04f05dff31483572e3","9f8c74cc480bb9188984ccde0d6ffbc55b52e9b9981e0d1107873efa3d44d4b6","a57e36d970134ce0407b75a116e63c9d94bf67970b0db0b925a423c5d121b521","a67f4a20eb0c0ccffc27a1e8d38ffa2a134e16af36d14f38de58bb0c8f97d95f","aa73b55042e26116520fa10a365056ff21cc35b158166eab5145b39258e52959","aede846965de4bd0ba8c9f0f9e511fe4c4d0462dd366aac1baebf4778505de16","b2055b161f2cdf2022778ae8f03795b8ed1fbbfb2b0ddce33e51569f32f6fcdc","b3794d62ae73542120efd20fa185bae10c52cdac2835803e7c45928d54a87bfd","be296673c86541c27c3af3f773b529dc19c60db5f36e32b1e82659c7b28a6a80","c0e9d80018f1f8465a7d3b185c59af37f750a1358a00f0b931fd84fa0a8bc930","c489155e2e22fa53d1fcfe081cde956c58a7c17529c931f8a4bbb7106bd78812","c4c57ee61db2dd489e765ec36f365797a75ccae4ceaf266bd7834f20c4e06eaa","cea990e189119fbf0672289340129d2bdbf319461ca5cc6e7048aeb26b55832f","d4d0fc35c13ba99aeb7c9be7710ec305f746e6f6e5cc6959505337d7794042a9","d9f4c1e270d7763f279a75d906139130b1baf1af8d7ff1fdef7058191f7b2443","da5036c9e20123b648722c791253cdc2ca578d52cef9f2de5c9bb07c091de32f","e15bfbdcbc17c2cf5aaca695b745457e23e131960a99de6575221dac3e3b9eb8","e273bc45e113d27b93fbd545d31d470e65aa09b2ce051fd1594aa309e97a580a","e2b312c361d132f7cd97ea90dd121c7996da76f3c8c108097bd329cf950c9092","ee008dd5c01fb25336eca24cdf1540ba8e114b7131668956a3f6ae5b5dfb1ff4","f8e5a557d1ac25f297b3efc773febcddb3f8b5f2db505bf38323619385d06c57","fd73b92c152db78ec98da46f00a8bef73b06009a9a364e7e28562b529b9b7835"],"recordQualifiers":{},"scopeLabel":"OMIM:151660","sourceIds":["OMIM:151660"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."},{"gene":"","key":"population-d02a61164d18466b2bb1","label":"Familial partial lipodystrophy, Dunnigan type","mondoId":"MONDO:0007906","onsetQualifier":null,"originColumnKey":"MONDO:0007906/ORPHA:2348","originalViews":[{"key":"MONDO:0007906/ORPHA:2348","label":"Familial partial lipodystrophy, Dunnigan type","scopeLabel":"ORPHA:2348","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["144ab91d17b5e8b1995edc70707ba9b1a88ed20c3f6e438e03adcdb7a77a667e","1f89f015e26f0456d3e3a29edaf04e12b53b212e4e7b86a361f0fc1172926004","25a3dfd39809c9e4d51dc5906596bf16141b61848255ce570b753ab41eeaa4fe","26a664c36fb962bda13e39a27a33a39023a77db68c9a9c7a4acfc1b19a654ab6","2bb544caa2e4504b088a7f33c5b8cc21573d3e5b0e6e4ce0c6e646321920addd","2db84ebfe8f4036709b4dced5600d05bd11e8b93cae1e6fa8d628390dad6fe55","389fa54030e1179b0968c0a28484fbfdf9f96041c91448685655cd2834950691","3bcdb4826d52e7e4355f5c6b474a896e20e8de322b9ce58c6eba4d51af395edc","46ac061299e5010bb09edc842674e16743106605019018bf5f074b6a9c88e027","47a583f30c94e95d5f975bc48bb84fe0bde3a2844ec0a3f0280f5cfd1b75a0b9","54aba63599ab07ea2453ccf317f28add127d69d64e25bdc58314ab310a328b24","6d42a5f09e332f6709dfda468425a09c14d3e41328dceea2e63f66909f2dbdf8","7714605a674fb97a758726aa30746b8ead98cf9119907217d5a6412ef689d5fe","7b948646982957a6571cdca140ffff7dd7952ffbd22e8bc345a1881234bcb9f7","84b878072a2bd13d8ef01f103e98edf3e2152fe1b77448d52fe61ba1e12fea94","86ec1f00ff67b9affc897a34b7c5ec32ff488cf508edff4c0d5682c78eee8fb3","916dc5feaf725652e1c6db2b54060999fdcb6dd26775e2ca85698fb982ab260e","9a085e12378dadd473eabdc4dab64d90ae336f8f83e2c1f15e9ebfed5336c0b5","a3a3c56577af0ada57fee24adea2291c27a502b5806ec019094733b39829274a","b347ac14f0beac752f764ab1740fd183f88f5eb10ccc7e46affae1727f4f0c74","b3e2e68fbe809aa62c13c7b5cd6bd43f24add45ffc6082be85fd7b902d50cc84","b676fd7e46334d8d3bdbf3af32628cad33b7a910023fc410cc001886240aa7a9","b93789453edfb65b999183b09f1ad3ca8c63e4207fb4cea06b4441751178d583","bc6dcdc83cfe8d858de33170596e91e24a69afa91caffc963e3f8a772e8641c8","c3a29e15e1e4528420bb03e000924c9270ee4810baa4eb396edde4a7e3cb9de0","cd368faed76aa9854e465b8c4cd82ab8f765263688980ca5f5c116d97c658b3e","d40cd19681db7b325e8a2f010aa2a108dce8ef305411c45f8f35bd163b75bfbb","d731efd7f1f30dc71d32cad8095b3c8787bb368b48fbd7414a6e3246c36d2c62","d95f6e8c4235cead8be89539071f7f80f496545319739f8f1c967bb47430a170","e5051312f6b639f9bc52fa7326ea42f9d10df424b4f5a699a86665e3b8cbc131","f027052f96b5f7de323b4f9d4dc93aecde1df00eda11b6c1e3c91941419c12f4","f704a89efc3be613b5caf735048c66b7a6bc5523b062d32086a9c1a4b6a97e52","fc5248c29650ec06d42d81b055dcf3f94ffa48381a5987ad53558b775d1c97c4"],"recordQualifiers":{},"scopeLabel":"ORPHA:2348","sourceIds":["ORPHA:2348"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-566da43eb690a6ae134e","population-d02a61164d18466b2bb1"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0012100","HP:0033477","HP:0001597","HP:0005339","HP:0012084","HP:0000956","HP:0001771"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":62,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":108,"sourceGroups":{"omim":13,"orphanet":33,"published":62}},"features":[{"hpoId":"HP:0012100","label":"Abnormal circulating creatinine concentration","primary":true},{"hpoId":"HP:0033477","label":"Abnormal circulating lipoprotein lipase concentration","primary":true},{"hpoId":"HP:0001597","label":"Abnormal nail morphology","primary":true},{"hpoId":"HP:0005339","label":"Abnormality of complement system","primary":true},{"hpoId":"HP:0012084","label":"Abnormality of skeletal muscle fiber size","primary":true},{"hpoId":"HP:0000956","label":"Acanthosis nigricans","primary":true},{"hpoId":"HP:0001771","label":"Achilles tendon contracture","primary":true},{"hpoId":"HP:0001735","label":"Acute pancreatitis","primary":false},{"hpoId":"HP:0008887","label":"Adipose tissue loss","primary":false},{"hpoId":"HP:0006288","label":"Advanced eruption of teeth","primary":false},{"hpoId":"HP:0012592","label":"Albuminuria","primary":false},{"hpoId":"HP:0001596","label":"Alopecia","primary":false},{"hpoId":"HP:0008065","label":"Aplasia/Hypoplasia of the skin","primary":false},{"hpoId":"HP:0002621","label":"Atherosclerosis","primary":false},{"hpoId":"HP:0005110","label":"Atrial fibrillation","primary":false},{"hpoId":"HP:0001678","label":"Atrioventricular block","primary":false},{"hpoId":"HP:0001638","label":"Cardiomyopathy","primary":false},{"hpoId":"HP:0100658","label":"Cellulitis","primary":false},{"hpoId":"HP:0001635","label":"Congestive heart failure","primary":false},{"hpoId":"HP:0012185","label":"Constrictive median neuropathy","primary":false},{"hpoId":"HP:0001677","label":"Coronary artery atherosclerosis","primary":false},{"hpoId":"HP:0006824","label":"Cranial nerve paralysis","primary":false},{"hpoId":"HP:0003233","label":"Decreased circulating HDL-C concentration","primary":false},{"hpoId":"HP:0000819","label":"Diabetes mellitus","primary":false},{"hpoId":"HP:0001644","label":"Dilated cardiomyopathy","primary":false},{"hpoId":"HP:0100607","label":"Dysmenorrhea","primary":false},{"hpoId":"HP:0031964","label":"Elevated circulating alanine aminotransferase concentration","primary":false},{"hpoId":"HP:0031956","label":"Elevated circulating aspartate aminotransferase concentration","primary":false},{"hpoId":"HP:0011227","label":"Elevated circulating C-reactive protein concentration","primary":false},{"hpoId":"HP:0003141","label":"Elevated circulating LDL-C concentration","primary":false},{"hpoId":"HP:0031185","label":"Elevated circulating NT-proBNP concentration","primary":false},{"hpoId":"HP:0040217","label":"Elevated hemoglobin A1c","primary":false},{"hpoId":"HP:0012645","label":"Enlarged peripheral nerve","primary":false},{"hpoId":"HP:0003738","label":"Exercise-induced myalgia","primary":false},{"hpoId":"HP:0001508","label":"Failure to thrive","primary":false},{"hpoId":"HP:0002230","label":"Generalized hirsutism","primary":false},{"hpoId":"HP:0009064","label":"Generalized lipodystrophy","primary":false},{"hpoId":"HP:0100820","label":"Glomerulopathy","primary":false},{"hpoId":"HP:0001952","label":"Glucose intolerance","primary":false},{"hpoId":"HP:0001397","label":"Hepatic steatosis","primary":false},{"hpoId":"HP:0002240","label":"Hepatomegaly","primary":false},{"hpoId":"HP:0001007","label":"Hirsutism","primary":false},{"hpoId":"HP:0003124","label":"Hypercholesterolemia","primary":false},{"hpoId":"HP:0003074","label":"Hyperglycemia","primary":false},{"hpoId":"HP:0000842","label":"Hyperinsulinemia","primary":false},{"hpoId":"HP:0000822","label":"Hypertension","primary":false},{"hpoId":"HP:0002155","label":"Hypertriglyceridemia","primary":false},{"hpoId":"HP:0001639","label":"Hypertrophic cardiomyopathy","primary":false},{"hpoId":"HP:0002149","label":"Hyperuricemia","primary":false},{"hpoId":"HP:0000468","label":"Increased adipose tissue around the neck","primary":false},{"hpoId":"HP:0030781","label":"Increased circulating free fatty acid level","primary":false},{"hpoId":"HP:0000287","label":"Increased facial adipose tissue","primary":false},{"hpoId":"HP:0008993","label":"Increased intraabdominal fat","primary":false},{"hpoId":"HP:0008985","label":"Increased intramuscular fat","primary":false},{"hpoId":"HP:0000855","label":"Insulin resistance","primary":false},{"hpoId":"HP:0000831","label":"Insulin-resistant diabetes mellitus","primary":false},{"hpoId":"HP:0008739","label":"Labial pseudohypertrophy","primary":false},{"hpoId":"HP:0100578","label":"Lipoatrophy","primary":false},{"hpoId":"HP:0009125","label":"Lipodystrophy","primary":false},{"hpoId":"HP:0003635","label":"Loss of subcutaneous adipose tissue in limbs","primary":false},{"hpoId":"HP:0009002","label":"Loss of truncal subcutaneous adipose tissue","primary":false},{"hpoId":"HP:0000347","label":"Micrognathia","primary":false},{"hpoId":"HP:0001070","label":"Mottled pigmentation","primary":false},{"hpoId":"HP:0001324","label":"Muscle weakness","primary":false},{"hpoId":"HP:0003560","label":"Muscular dystrophy","primary":false},{"hpoId":"HP:0003326","label":"Myalgia","primary":false},{"hpoId":"HP:0003198","label":"Myopathy","primary":false},{"hpoId":"HP:0002486","label":"Myotonia","primary":false},{"hpoId":"HP:0001513","label":"Obesity","primary":false},{"hpoId":"HP:0000939","label":"Osteoporosis","primary":false},{"hpoId":"HP:0025502","label":"Overweight","primary":false},{"hpoId":"HP:0001733","label":"Pancreatitis","primary":false},{"hpoId":"HP:0000147","label":"Polycystic ovaries","primary":false},{"hpoId":"HP:0005181","label":"Premature coronary artery atherosclerosis","primary":false},{"hpoId":"HP:0008209","label":"Premature ovarian insufficiency","primary":false},{"hpoId":"HP:0005328","label":"Progeroid facial appearance","primary":false},{"hpoId":"HP:0001657","label":"Prolonged QT interval","primary":false},{"hpoId":"HP:0007394","label":"Prominent superficial blood vessels","primary":false},{"hpoId":"HP:0001015","label":"Prominent superficial veins","primary":false},{"hpoId":"HP:0000520","label":"Proptosis","primary":false},{"hpoId":"HP:0003758","label":"Reduced subcutaneous adipose tissue","primary":false},{"hpoId":"HP:0000311","label":"Round face","primary":false},{"hpoId":"HP:0100324","label":"Scleroderma","primary":false},{"hpoId":"HP:0002650","label":"Scoliosis","primary":false},{"hpoId":"HP:0000869","label":"Secondary amenorrhea","primary":false},{"hpoId":"HP:0004322","label":"Short stature","primary":false},{"hpoId":"HP:0003712","label":"Skeletal muscle hypertrophy","primary":false},{"hpoId":"HP:0001744","label":"Splenomegaly","primary":false},{"hpoId":"HP:0000963","label":"Thin skin","primary":false},{"hpoId":"HP:0005978","label":"Type II diabetes mellitus","primary":false},{"hpoId":"HP:0000991","label":"Xanthomatosis","primary":false}],"ledeHtml":"Familial partial lipodystrophy, Dunnigan type (FPLD2) is a rare, genetic disorder that affects the amount and distribution of fat (adipose tissue) in the body. Symptoms typically develop around puberty, after having normal adipose tissue in childhood. FPLD2 causes a loss of adipose tissue from the limbs, torso, buttocks and hips, while causing a buildup of adipose tissue in the face, neck, and upper back. It may also cause increased musculature. Some people with FPLD2 have areas of dark, thick skin (acanthosis nigricans), and females may have excessive hairiness (hirsutism) and menstrual abnormalities. Metabolic abnormalities develop in adolescence or adulthood, leading to signs and symptoms that may include insulin resistance, dyslipidemia, diabetes, pancreatitis (or recurrent acute pancreatitis), liver steatosis, atherosclerosis, and an increased risk of heart disease. FPLD2 is caused by genetic changes in the LMNA gene and inheritance is autosomal dominant.","mondoId":"MONDO:0007906","node":{"canonicalSlug":"familial-partial-lipodystrophy-dunnigan-type","comparisons":[],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Familial partial lipodystrophy, Dunnigan type","originalSourceId":"ORPHA:2348","paragraphs":["Familial partial lipodystrophy, Dunnigan type (FPLD2) is a rare, genetic disorder that affects the amount and distribution of fat (adipose tissue) in the body. Symptoms typically develop around puberty, after having normal adipose tissue in childhood. FPLD2 causes a loss of adipose tissue from the limbs, torso, buttocks and hips, while causing a buildup of adipose tissue in the face, neck, and upper back. It may also cause increased musculature. Some people with FPLD2 have areas of dark, thick skin (acanthosis nigricans), and females may have excessive hairiness (hirsutism) and menstrual abnormalities. Metabolic abnormalities develop in adolescence or adulthood, leading to signs and symptoms that may include insulin resistance, dyslipidemia, diabetes, pancreatitis (or recurrent acute pancreatitis), liver steatosis, atherosclerosis, and an increased risk of heart disease. FPLD2 is caused by genetic changes in the LMNA gene and inheritance is autosomal dominant."],"rawAttribution":"MONDO:0007906","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-25T03:38:56Z","upstream":"GARD:0003126","url":"https://rarediseases.info.nih.gov/diseases/3126"},"ownColumnKeys":["population-566da43eb690a6ae134e","population-d02a61164d18466b2bb1"],"publication":"published","relationships":[{"kind":"parent","label":"familial partial lipodystrophy","mondoId":"MONDO:0020088","slug":"familial-partial-lipodystrophy"},{"kind":"parent","label":"disorder of development or morphogenesis","mondoId":"MONDO:0021147","slug":null}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"count","key":"022c5452e62cf0d6c4141efc6c772d109f92078f10481bf271db902aa877716f","raw":{"aspect":"P","body_system":"skin","disease_id":"OMIM:151660","disease_name":"Lipodystrophy, familial partial, type 2","evidence":"PCS","frequency_raw":"4/4","hpo_id":"HP:0000991","is_excluded":false,"label":"Xanthomatosis","onset_id":null,"reference":"PMID:17250669;PMID:11344241","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"034bd43e82d58b524bb95de231e735c5a1d92be8862ce66c88dedfdb30842721","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:151660","disease_name":"Lipodystrophy, familial partial, type 2","evidence":"PCS","frequency_raw":"1/6","hpo_id":"HP:0001657","is_excluded":false,"label":"Prolonged QT interval","onset_id":null,"reference":"PMID:37303127","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"07baaee4dff30391fa40f4082da4fbb278ae4a46411c87f975f17d2c6b7e1fbb","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:151660","disease_name":"Lipodystrophy, familial partial, type 2","evidence":"PCS","frequency_raw":"5/5","hpo_id":"HP:0003198","is_excluded":false,"label":"Myopathy","onset_id":null,"reference":"PMID:17250669;PMID:11344241","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"0a9dc38a6579ca2678e3224f1d9f04f217b48867a2c795524de7e74feec5a964","raw":{"aspect":"P","body_system":"skin","disease_id":"OMIM:151660","disease_name":"Lipodystrophy, familial partial, type 2","evidence":"PCS","frequency_raw":"3/4","hpo_id":"HP:0000956","is_excluded":false,"label":"Acanthosis nigricans","onset_id":null,"reference":"PMID:17250669;PMID:11344241","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"0ab0a4a6aebaf9bb66f734afa5f5e15502e1e464a2a46ced53b72bc188d0c299","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:151660","disease_name":"Lipodystrophy, familial partial, type 2","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0000287","is_excluded":false,"label":"Increased facial adipose tissue","onset_id":null,"reference":"PMID:17250669","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"11df62bf6c1af9176ccb56482a42e3f759aa067fe426985d6f8a5dbddd3b023d","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"OMIM:151660","disease_name":"Lipodystrophy, familial partial, type 2","evidence":"PCS","frequency_raw":"1/4","hpo_id":"HP:0008209","is_excluded":false,"label":"Premature ovarian insufficiency","onset_id":null,"reference":"PMID:37303127","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"144ab91d17b5e8b1995edc70707ba9b1a88ed20c3f6e438e03adcdb7a77a667e","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:2348","disease_name":"Familial partial lipodystrophy, Dunnigan type","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0003198","is_excluded":false,"label":"Myopathy","onset_id":null,"reference":"ORPHA:2348","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"1602c99bd01e224b65b63c0b83a3e35992574b33d3a811146a67564dcb45ea74","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:151660","disease_name":"Lipodystrophy, familial partial, type 2","evidence":"PCS","frequency_raw":"1/3","hpo_id":"HP:0000822","is_excluded":false,"label":"Hypertension","onset_id":"HP:0003584","reference":"PMID:17250669","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"1737cd8e2e37f5ea3ab8ccf44854b1fbd68ae0979979285af683b86bd2042672","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:151660","disease_name":"Lipodystrophy, familial partial, type 2","evidence":"PCS","frequency_raw":"121/121","hpo_id":"HP:0003635","is_excluded":false,"label":"Loss of subcutaneous adipose tissue in limbs","onset_id":null,"reference":"PMID:37843397;PMID:17250669;PMID:11344241","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"18a15951c99e8d83592e9078f8537e0891fc9c22776b85789f5251fc0094f583","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:151660","disease_name":"Lipodystrophy, familial partial, type 2","evidence":"PCS","frequency_raw":"6/6","hpo_id":"HP:0000855","is_excluded":false,"label":"Insulin resistance","onset_id":null,"reference":"PMID:37303127","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"1e606f29c6ae8d436fee98f195b40ab2a8ce938a112c306d0302280654a7653d","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:151660","disease_name":"Lipodystrophy, familial partial, type 2","evidence":"PCS","frequency_raw":"1/6","hpo_id":"HP:0002486","is_excluded":false,"label":"Myotonia","onset_id":null,"reference":"PMID:37303127","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"1f33a768e1a6672142d81fd254d411bb62507165e55b90f2cb5c11fb58de8d5a","raw":{"aspect":"P","body_system":"digestive","disease_id":"OMIM:151660","disease_name":"Lipodystrophy, familial partial, type 2","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0001744","is_excluded":false,"label":"Splenomegaly","onset_id":null,"reference":"PMID:11344241","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"1f74cbf217d9ec5a667a760cb443cfa8d3ba0d4e056047af3b65e5054fc2a9fb","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:151660","disease_name":"Lipodystrophy, familial partial, type 2","evidence":"PCS","frequency_raw":"1/6","hpo_id":"HP:0001771","is_excluded":false,"label":"Achilles tendon contracture","onset_id":null,"reference":"PMID:37303127","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"1f89f015e26f0456d3e3a29edaf04e12b53b212e4e7b86a361f0fc1172926004","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:2348","disease_name":"Familial partial lipodystrophy, Dunnigan type","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002621","is_excluded":false,"label":"Atherosclerosis","onset_id":null,"reference":"ORPHA:2348","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"2119121586ec867b5e8912c21e3ab2c67c5ae4c7494f7a719b30ce1501a4516b","raw":{"aspect":"P","body_system":"skin","disease_id":"OMIM:151660","disease_name":"Lipodystrophy, familial partial, type 2","evidence":"PCS","frequency_raw":"0/3","hpo_id":"HP:0001070","is_excluded":true,"label":"Mottled pigmentation","onset_id":null,"reference":"PMID:17250669","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"247a53904a005caf283e1dd2867ed091c25d4075951dd43e04368cde62306753","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:151660","disease_name":"Lipodystrophy, familial partial, type 2","evidence":"PCS","frequency_raw":"3/6","hpo_id":"HP:0031964","is_excluded":false,"label":"Elevated circulating alanine aminotransferase concentration","onset_id":null,"reference":"PMID:37303127","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"25134b1d6c8c10353badf7f269cb8552e25900b9c79d52d5d316cb3ab00b3885","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:151660","disease_name":"Lipodystrophy, familial partial, type 2","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0008993","is_excluded":false,"label":"Increased intraabdominal fat","onset_id":null,"reference":"OMIM:151660","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"25a3dfd39809c9e4d51dc5906596bf16141b61848255ce570b753ab41eeaa4fe","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:2348","disease_name":"Familial partial lipodystrophy, Dunnigan type","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003635","is_excluded":false,"label":"Loss of subcutaneous adipose tissue in limbs","onset_id":null,"reference":"ORPHA:2348","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"26a664c36fb962bda13e39a27a33a39023a77db68c9a9c7a4acfc1b19a654ab6","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:2348","disease_name":"Familial partial lipodystrophy, Dunnigan type","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001677","is_excluded":false,"label":"Coronary artery atherosclerosis","onset_id":null,"reference":"ORPHA:2348","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"27f483ccada249fb34b9f0cab64178588c98e670a6bf91f3778da5be14f274fc","raw":{"aspect":"P","body_system":"digestive","disease_id":"OMIM:151660","disease_name":"Lipodystrophy, familial partial, type 2","evidence":"PCS","frequency_raw":"18/117","hpo_id":"HP:0001733","is_excluded":false,"label":"Pancreatitis","onset_id":null,"reference":"PMID:37843397;PMID:17250669","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"293558c9f4953aaf6a7b06484b0406763dc12a1777aae24fed32c0017d5d19f3","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:151660","disease_name":"Lipodystrophy, familial partial, type 2","evidence":"PCS","frequency_raw":"3/6","hpo_id":"HP:0031956","is_excluded":false,"label":"Elevated circulating aspartate aminotransferase concentration","onset_id":null,"reference":"PMID:37303127","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"2ae4b79bc4eba97dc6fc7728f5eac69f124e86bcaa12cf72fafe89404dc7dac4","raw":{"aspect":"P","body_system":"endocrine","disease_id":"OMIM:151660","disease_name":"Lipodystrophy, familial partial, type 2","evidence":"PCS","frequency_raw":"89/122","hpo_id":"HP:0005978","is_excluded":false,"label":"Type II diabetes mellitus","onset_id":null,"reference":"PMID:37843397;PMID:37303127;PMID:17250669;PMID:11344241","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"2b391efffd1e84b2407a392d447db7c7e34455b23261be402df4285db81a6da2","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:151660","disease_name":"Lipodystrophy, familial partial, type 2","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0012645","is_excluded":false,"label":"Enlarged peripheral nerve","onset_id":null,"reference":"OMIM:151660","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"2bb544caa2e4504b088a7f33c5b8cc21573d3e5b0e6e4ce0c6e646321920addd","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:2348","disease_name":"Familial partial lipodystrophy, Dunnigan type","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0012084","is_excluded":false,"label":"Abnormality of skeletal muscle fiber size","onset_id":null,"reference":"ORPHA:2348","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"2d9421db7a874ba6cf9cea30ac1642ddbf83fb275c41847f08d36fa3fc1cce38","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:151660","disease_name":"Lipodystrophy, familial partial, type 2","evidence":"PCS","frequency_raw":"3/6","hpo_id":"HP:0002149","is_excluded":false,"label":"Hyperuricemia","onset_id":null,"reference":"PMID:37303127","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"2db84ebfe8f4036709b4dced5600d05bd11e8b93cae1e6fa8d628390dad6fe55","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:2348","disease_name":"Familial partial lipodystrophy, Dunnigan type","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000963","is_excluded":false,"label":"Thin skin","onset_id":null,"reference":"ORPHA:2348","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"2de76532d475929f6836fcdf34b1216c76658bd96952f0574308cf26b3c05b23","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:151660","disease_name":"Lipodystrophy, familial partial, type 2","evidence":"PCS","frequency_raw":"70/119","hpo_id":"HP:0003233","is_excluded":false,"label":"Decreased circulating HDL-C concentration","onset_id":null,"reference":"PMID:37843397;PMID:37303127;PMID:17250669;PMID:11344241","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"2df6cfe61cc5ed12ebb0991e18687da6b5a8a6def020c6061a7296f86a6d69fd","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"OMIM:151660","disease_name":"Lipodystrophy, familial partial, type 2","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000311","is_excluded":false,"label":"Round face","onset_id":null,"reference":"OMIM:151660","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"2edb5222e43e5ea459ef80e5f67b31c4a5fa387b9ebe187abad3c94615132b06","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:151660","disease_name":"Lipodystrophy, familial partial, type 2","evidence":"PCS","frequency_raw":"0/1","hpo_id":"HP:0007394","is_excluded":true,"label":"Prominent superficial blood vessels","onset_id":null,"reference":"PMID:17250669","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"33c453ef6387432fb7336543ebd2e4d1dcf2176776c72768c4ad462cb7749d0e","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"OMIM:151660","disease_name":"Lipodystrophy, familial partial, type 2","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0008739","is_excluded":false,"label":"Labial pseudohypertrophy","onset_id":null,"reference":"OMIM:151660","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"389fa54030e1179b0968c0a28484fbfdf9f96041c91448685655cd2834950691","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:2348","disease_name":"Familial partial lipodystrophy, Dunnigan type","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000869","is_excluded":false,"label":"Secondary amenorrhea","onset_id":null,"reference":"ORPHA:2348","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"3af887ba84ea931f890568234cb083b3b0d23263faf03a811eef9012d6f1b812","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:151660","disease_name":"Lipodystrophy, familial partial, type 2","evidence":"PCS","frequency_raw":"10/12","hpo_id":"HP:0001015","is_excluded":false,"label":"Prominent superficial veins","onset_id":null,"reference":"OMIM:151660;PMID:17250669","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"3bcdb4826d52e7e4355f5c6b474a896e20e8de322b9ce58c6eba4d51af395edc","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:2348","disease_name":"Familial partial lipodystrophy, Dunnigan type","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0008065","is_excluded":false,"label":"Aplasia/Hypoplasia of the skin","onset_id":null,"reference":"ORPHA:2348","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"3cc8c84c04bfb7977caa93c2fc9eb0e018221039ef5bdc1e19c51189fa063262","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:151660","disease_name":"Lipodystrophy, familial partial, type 2","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0008985","is_excluded":false,"label":"Increased intramuscular fat","onset_id":null,"reference":"OMIM:151660","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"3f1d04cded8423a50a6bdb138dcb636ffa785f120921a2a1c4d0b0112cf52796","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"OMIM:151660","disease_name":"Lipodystrophy, familial partial, type 2","evidence":"PCS","frequency_raw":"0/3","hpo_id":"HP:0000347","is_excluded":true,"label":"Micrognathia","onset_id":null,"reference":"PMID:17250669","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"3fce67dd415318de1d91a07f854c5e806ca3b8c0bca2f3a691ee4d1019b01f84","raw":{"aspect":"P","body_system":"skin","disease_id":"OMIM:151660","disease_name":"Lipodystrophy, familial partial, type 2","evidence":"PCS","frequency_raw":"0/3","hpo_id":"HP:0100324","is_excluded":true,"label":"Scleroderma","onset_id":null,"reference":"PMID:17250669","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"451aa8f813298bbfcb6d5aefcd350fe3293d43a8fd969a0ba0d9ba62300be338","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:151660","disease_name":"Lipodystrophy, familial partial, type 2","evidence":"PCS","frequency_raw":"79/110","hpo_id":"HP:0040217","is_excluded":false,"label":"Elevated hemoglobin A1c","onset_id":null,"reference":"PMID:37843397;PMID:37303127;PMID:17250669;PMID:11344241","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"46ac061299e5010bb09edc842674e16743106605019018bf5f074b6a9c88e027","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:2348","disease_name":"Familial partial lipodystrophy, Dunnigan type","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002230","is_excluded":false,"label":"Generalized hirsutism","onset_id":null,"reference":"ORPHA:2348","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"47a583f30c94e95d5f975bc48bb84fe0bde3a2844ec0a3f0280f5cfd1b75a0b9","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:2348","disease_name":"Familial partial lipodystrophy, Dunnigan type","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001639","is_excluded":false,"label":"Hypertrophic cardiomyopathy","onset_id":null,"reference":"ORPHA:2348","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"4b52270734efff69002c81feed91074ad8426c5574e40ce142db69cf54b5c5a6","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:151660","disease_name":"Lipodystrophy, familial partial, type 2","evidence":"PCS","frequency_raw":"5/5","hpo_id":"HP:0003712","is_excluded":false,"label":"Skeletal muscle hypertrophy","onset_id":null,"reference":"PMID:17250669;PMID:11344241","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"54aba63599ab07ea2453ccf317f28add127d69d64e25bdc58314ab310a328b24","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:2348","disease_name":"Familial partial lipodystrophy, Dunnigan type","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0100578","is_excluded":false,"label":"Lipoatrophy","onset_id":null,"reference":"ORPHA:2348","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"556f48a1bd8b693a85f7fe4ac29778e7b465386cc7b6847883b2525168b57b35","raw":{"aspect":"P","body_system":"digestive","disease_id":"OMIM:151660","disease_name":"Lipodystrophy, familial partial, type 2","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0002240","is_excluded":false,"label":"Hepatomegaly","onset_id":null,"reference":"PMID:11344241","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"563bc60871e5a262ad7fb06805a027fce8e5ac7122aae5fd96f1ccde2f0151ea","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:151660","disease_name":"Lipodystrophy, familial partial, type 2","evidence":"PCS","frequency_raw":"0/4","hpo_id":"HP:0001324","is_excluded":true,"label":"Muscle weakness","onset_id":null,"reference":"PMID:17250669;PMID:11344241","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"57bd1880e55496d2583237d872a592c7bca784ab4a6ae87dded226251f625ee7","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"OMIM:151660","disease_name":"Lipodystrophy, familial partial, type 2","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000147","is_excluded":false,"label":"Polycystic ovaries","onset_id":null,"reference":"OMIM:151660","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"58252a52ff0f352fe2cb079bfe52f0d9b2c7f56826ff979d858f1eb17c648082","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:151660","disease_name":"Lipodystrophy, familial partial, type 2","evidence":"PCS","frequency_raw":"2/6","hpo_id":"HP:0000939","is_excluded":false,"label":"Osteoporosis","onset_id":null,"reference":"PMID:37303127","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"58c95f3d63d335e4d955e82bda995625140088bf9eb89e85ae320c4145039b56","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:151660","disease_name":"Lipodystrophy, familial partial, type 2","evidence":"PCS","frequency_raw":"2/6","hpo_id":"HP:0001635","is_excluded":false,"label":"Congestive heart failure","onset_id":null,"reference":"PMID:37303127","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"605f9079ae4a311ebb8c79d4281049372eef9d547aec9693cadf15d3deb79a5b","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:151660","disease_name":"Lipodystrophy, familial partial, type 2","evidence":"PCS","frequency_raw":"1/4","hpo_id":"HP:0001638","is_excluded":false,"label":"Cardiomyopathy","onset_id":null,"reference":"PMID:37303127;PMID:17250669","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"618bd33ca3f2ffb94e4e74854ecfd86adb31ee2700e827fc9981ba48050fee15","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:151660","disease_name":"Lipodystrophy, familial partial, type 2","evidence":"PCS","frequency_raw":"8/9","hpo_id":"HP:0003074","is_excluded":false,"label":"Hyperglycemia","onset_id":null,"reference":"PMID:37303127;PMID:17250669","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"650fe688b0051f4850263ceafa8600e390fe4165b28f2c103db00cea62ad1395","raw":{"aspect":"P","body_system":"growth","disease_id":"OMIM:151660","disease_name":"Lipodystrophy, familial partial, type 2","evidence":"PCS","frequency_raw":"21/103","hpo_id":"HP:0001513","is_excluded":false,"label":"Obesity","onset_id":null,"reference":"PMID:37843397;PMID:17250669;PMID:11344241","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"69e2ad7cc522c758abf49e6a5b6d6398a4f70f5843525107662a42cc8f51049b","raw":{"aspect":"P","body_system":"skin","disease_id":"OMIM:151660","disease_name":"Lipodystrophy, familial partial, type 2","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001007","is_excluded":false,"label":"Hirsutism","onset_id":null,"reference":"OMIM:151660","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"6d42a5f09e332f6709dfda468425a09c14d3e41328dceea2e63f66909f2dbdf8","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:2348","disease_name":"Familial partial lipodystrophy, Dunnigan type","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000819","is_excluded":false,"label":"Diabetes mellitus","onset_id":null,"reference":"ORPHA:2348","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"713de590eb24f07c77b45c6e6cddc3b6f65988a3b6d98ca88dd239a91c19250d","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:151660","disease_name":"Lipodystrophy, familial partial, type 2","evidence":"PCS","frequency_raw":"0/3","hpo_id":"HP:0000520","is_excluded":true,"label":"Proptosis","onset_id":null,"reference":"PMID:17250669","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"72acb0026cc6c8606eb36eb3f7d799d3d8c08a8fe0c964e36ce55a09baa428da","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:151660","disease_name":"Lipodystrophy, familial partial, type 2","evidence":"PCS","frequency_raw":"3/6","hpo_id":"HP:0012592","is_excluded":false,"label":"Albuminuria","onset_id":null,"reference":"PMID:37303127","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"7714605a674fb97a758726aa30746b8ead98cf9119907217d5a6412ef689d5fe","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:2348","disease_name":"Familial partial lipodystrophy, Dunnigan type","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001597","is_excluded":false,"label":"Abnormal nail morphology","onset_id":null,"reference":"ORPHA:2348","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"79c56079c976fef2ed2d5c31ccde44432690727feba6747b23b437140c234ce8","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:151660","disease_name":"Lipodystrophy, familial partial, type 2","evidence":"PCS","frequency_raw":"2/6","hpo_id":"HP:0002650","is_excluded":false,"label":"Scoliosis","onset_id":null,"reference":"PMID:37303127","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"7a21bed4dbfea8debb136c53b814811bce95f7d16da5cb211210f20b8b4e4723","raw":{"aspect":"P","body_system":"other","disease_id":"OMIM:151660","disease_name":"Lipodystrophy, familial partial, type 2","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0003326","is_excluded":false,"label":"Myalgia","onset_id":null,"reference":"OMIM:151660","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"7b948646982957a6571cdca140ffff7dd7952ffbd22e8bc345a1881234bcb9f7","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:2348","disease_name":"Familial partial lipodystrophy, Dunnigan type","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001635","is_excluded":false,"label":"Congestive heart failure","onset_id":null,"reference":"ORPHA:2348","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"84893d80c37bc21207941223d6e8d6c0471c09de79b8d04c080d2251ad2d5daa","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:151660","disease_name":"Lipodystrophy, familial partial, type 2","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002621","is_excluded":false,"label":"Atherosclerosis","onset_id":null,"reference":"OMIM:151660","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"84b878072a2bd13d8ef01f103e98edf3e2152fe1b77448d52fe61ba1e12fea94","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"ORPHA:2348","disease_name":"Familial partial lipodystrophy, Dunnigan type","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0006288","is_excluded":false,"label":"Advanced eruption of teeth","onset_id":null,"reference":"ORPHA:2348","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"86ec1f00ff67b9affc897a34b7c5ec32ff488cf508edff4c0d5682c78eee8fb3","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:2348","disease_name":"Familial partial lipodystrophy, Dunnigan type","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000147","is_excluded":false,"label":"Polycystic ovaries","onset_id":null,"reference":"ORPHA:2348","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"87ee8ee2506f4825fc7314d88dddd2daf8667269f3866c114094d73064308746","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:151660","disease_name":"Lipodystrophy, familial partial, type 2","evidence":"PCS","frequency_raw":"79/118","hpo_id":"HP:0002155","is_excluded":false,"label":"Hypertriglyceridemia","onset_id":null,"reference":"PMID:37843397;PMID:37303127;PMID:17250669;PMID:11344241","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"916dc5feaf725652e1c6db2b54060999fdcb6dd26775e2ca85698fb982ab260e","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:2348","disease_name":"Familial partial lipodystrophy, Dunnigan type","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000956","is_excluded":false,"label":"Acanthosis nigricans","onset_id":null,"reference":"ORPHA:2348","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"93abe455de59d1dc7b81389841c1ef1e602766d36354dee7e93af4b036a51b37","raw":{"aspect":"P","body_system":"other","disease_id":"OMIM:151660","disease_name":"Lipodystrophy, familial partial, type 2","evidence":"PCS","frequency_raw":"3/3","hpo_id":"HP:0003738","is_excluded":false,"label":"Exercise-induced myalgia","onset_id":null,"reference":"PMID:11344241","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"93ddb12f5e464f01b0428e1f3c9ab921db2f4758562fe96e0063f8c477593ca3","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:151660","disease_name":"Lipodystrophy, familial partial, type 2","evidence":"PCS","frequency_raw":"3/6","hpo_id":"HP:0030781","is_excluded":false,"label":"Increased circulating free fatty acid level","onset_id":null,"reference":"PMID:37303127","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"9467b546bc3b6ff69306a0dc3701a9140b6071288f038fffb95768c00f6a0737","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:151660","disease_name":"Lipodystrophy, familial partial, type 2","evidence":"PCS","frequency_raw":"1/6","hpo_id":"HP:0003560","is_excluded":false,"label":"Muscular dystrophy","onset_id":null,"reference":"PMID:37303127","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"94e0e542b1239cacae6c5f306fd8f5340845c6a3285960e4ce39b3ecf067323e","raw":{"aspect":"P","body_system":"endocrine","disease_id":"OMIM:151660","disease_name":"Lipodystrophy, familial partial, type 2","evidence":"PCS","frequency_raw":"3/3","hpo_id":"HP:0000831","is_excluded":false,"label":"Insulin-resistant diabetes mellitus","onset_id":null,"reference":"PMID:17250669","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"96c0ff4ec554b5995acc9db4f01f8980c60b38c326e7d8458c46a817430271fa","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:151660","disease_name":"Lipodystrophy, familial partial, type 2","evidence":"PCS","frequency_raw":"3/101","hpo_id":"HP:0001644","is_excluded":false,"label":"Dilated cardiomyopathy","onset_id":null,"reference":"PMID:37843397;PMID:37303127","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"9927fd9c0d8de653fcf80927f0fd68556e4a3f091ae84426508d4f1da6c4b505","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:151660","disease_name":"Lipodystrophy, familial partial, type 2","evidence":"PCS","frequency_raw":"0/1","hpo_id":"HP:0033477","is_excluded":true,"label":"Abnormal circulating lipoprotein lipase concentration","onset_id":null,"reference":"PMID:11344241","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"9a085e12378dadd473eabdc4dab64d90ae336f8f83e2c1f15e9ebfed5336c0b5","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:2348","disease_name":"Familial partial lipodystrophy, Dunnigan type","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001397","is_excluded":false,"label":"Hepatic steatosis","onset_id":null,"reference":"ORPHA:2348","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"9a61e4e3d0af9e3a4699839ccb8c0e47abd1ccffc3d22f97606846f667a2137c","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:151660","disease_name":"Lipodystrophy, familial partial, type 2","evidence":"PCS","frequency_raw":"25/110","hpo_id":"HP:0003141","is_excluded":false,"label":"Elevated circulating LDL-C concentration","onset_id":null,"reference":"PMID:37843397;PMID:37303127;PMID:17250669","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"9b8129da136729144b6cc561656db17c69c2fb6f3b2d88ad3f61b1c3f969fedc","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:151660","disease_name":"Lipodystrophy, familial partial, type 2","evidence":"PCS","frequency_raw":"4/6","hpo_id":"HP:0011227","is_excluded":false,"label":"Elevated circulating C-reactive protein concentration","onset_id":null,"reference":"PMID:37303127","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"9bef9c42a749512d43546540fb98f61fed193af54a8e9c04f05dff31483572e3","raw":{"aspect":"P","body_system":"skin","disease_id":"OMIM:151660","disease_name":"Lipodystrophy, familial partial, type 2","evidence":"PCS","frequency_raw":"0/3","hpo_id":"HP:0001596","is_excluded":true,"label":"Alopecia","onset_id":null,"reference":"PMID:17250669","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"9f8c74cc480bb9188984ccde0d6ffbc55b52e9b9981e0d1107873efa3d44d4b6","raw":{"aspect":"P","body_system":"growth","disease_id":"OMIM:151660","disease_name":"Lipodystrophy, familial partial, type 2","evidence":"PCS","frequency_raw":"0/3","hpo_id":"HP:0001508","is_excluded":true,"label":"Failure to thrive","onset_id":null,"reference":"PMID:17250669","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"a3a3c56577af0ada57fee24adea2291c27a502b5806ec019094733b39829274a","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"ORPHA:2348","disease_name":"Familial partial lipodystrophy, Dunnigan type","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000311","is_excluded":false,"label":"Round face","onset_id":null,"reference":"ORPHA:2348","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"a57e36d970134ce0407b75a116e63c9d94bf67970b0db0b925a423c5d121b521","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:151660","disease_name":"Lipodystrophy, familial partial, type 2","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0008887","is_excluded":false,"label":"Adipose tissue loss","onset_id":null,"reference":"OMIM:151660","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"a67f4a20eb0c0ccffc27a1e8d38ffa2a134e16af36d14f38de58bb0c8f97d95f","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:151660","disease_name":"Lipodystrophy, familial partial, type 2","evidence":"PCS","frequency_raw":"9/115","hpo_id":"HP:0005181","is_excluded":false,"label":"Premature coronary artery atherosclerosis","onset_id":null,"reference":"PMID:37843397","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"aa73b55042e26116520fa10a365056ff21cc35b158166eab5145b39258e52959","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:151660","disease_name":"Lipodystrophy, familial partial, type 2","evidence":"PCS","frequency_raw":"1/6","hpo_id":"HP:0005110","is_excluded":false,"label":"Atrial fibrillation","onset_id":null,"reference":"PMID:37303127","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"aede846965de4bd0ba8c9f0f9e511fe4c4d0462dd366aac1baebf4778505de16","raw":{"aspect":"P","body_system":"skin","disease_id":"OMIM:151660","disease_name":"Lipodystrophy, familial partial, type 2","evidence":"PCS","frequency_raw":"2/9","hpo_id":"HP:0005328","is_excluded":false,"label":"Progeroid facial appearance","onset_id":null,"reference":"PMID:37303127;PMID:17250669","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"b2055b161f2cdf2022778ae8f03795b8ed1fbbfb2b0ddce33e51569f32f6fcdc","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:151660","disease_name":"Lipodystrophy, familial partial, type 2","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0001952","is_excluded":false,"label":"Glucose intolerance","onset_id":null,"reference":"PMID:37303127","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"b347ac14f0beac752f764ab1740fd183f88f5eb10ccc7e46affae1727f4f0c74","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:2348","disease_name":"Familial partial lipodystrophy, Dunnigan type","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0005339","is_excluded":false,"label":"Abnormality of complement system","onset_id":null,"reference":"ORPHA:2348","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"b3794d62ae73542120efd20fa185bae10c52cdac2835803e7c45928d54a87bfd","raw":{"aspect":"P","body_system":"growth","disease_id":"OMIM:151660","disease_name":"Lipodystrophy, familial partial, type 2","evidence":"PCS","frequency_raw":"1/5","hpo_id":"HP:0004322","is_excluded":false,"label":"Short stature","onset_id":null,"reference":"PMID:37303127;PMID:17250669","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"b3e2e68fbe809aa62c13c7b5cd6bd43f24add45ffc6082be85fd7b902d50cc84","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:2348","disease_name":"Familial partial lipodystrophy, Dunnigan type","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0100820","is_excluded":false,"label":"Glomerulopathy","onset_id":null,"reference":"ORPHA:2348","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"b676fd7e46334d8d3bdbf3af32628cad33b7a910023fc410cc001886240aa7a9","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:2348","disease_name":"Familial partial lipodystrophy, Dunnigan type","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0002155","is_excluded":false,"label":"Hypertriglyceridemia","onset_id":null,"reference":"ORPHA:2348","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"b93789453edfb65b999183b09f1ad3ca8c63e4207fb4cea06b4441751178d583","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:2348","disease_name":"Familial partial lipodystrophy, Dunnigan type","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0002240","is_excluded":false,"label":"Hepatomegaly","onset_id":null,"reference":"ORPHA:2348","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"bc6dcdc83cfe8d858de33170596e91e24a69afa91caffc963e3f8a772e8641c8","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:2348","disease_name":"Familial partial lipodystrophy, Dunnigan type","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003712","is_excluded":false,"label":"Skeletal muscle hypertrophy","onset_id":null,"reference":"ORPHA:2348","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"be296673c86541c27c3af3f773b529dc19c60db5f36e32b1e82659c7b28a6a80","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:151660","disease_name":"Lipodystrophy, familial partial, type 2","evidence":"PCS","frequency_raw":"121/121","hpo_id":"HP:0009125","is_excluded":false,"label":"Lipodystrophy","onset_id":null,"reference":"PMID:37843397;PMID:37303127;PMID:17250669;PMID:11344241","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"c0e9d80018f1f8465a7d3b185c59af37f750a1358a00f0b931fd84fa0a8bc930","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"OMIM:151660","disease_name":"Lipodystrophy, familial partial, type 2","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000468","is_excluded":false,"label":"Increased adipose tissue around the neck","onset_id":null,"reference":"OMIM:151660","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"c3a29e15e1e4528420bb03e000924c9270ee4810baa4eb396edde4a7e3cb9de0","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:2348","disease_name":"Familial partial lipodystrophy, Dunnigan type","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001744","is_excluded":false,"label":"Splenomegaly","onset_id":null,"reference":"ORPHA:2348","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"c489155e2e22fa53d1fcfe081cde956c58a7c17529c931f8a4bbb7106bd78812","raw":{"aspect":"P","body_system":"growth","disease_id":"OMIM:151660","disease_name":"Lipodystrophy, familial partial, type 2","evidence":"PCS","frequency_raw":"42/102","hpo_id":"HP:0025502","is_excluded":false,"label":"Overweight","onset_id":null,"reference":"PMID:37843397;PMID:17250669","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"c4c57ee61db2dd489e765ec36f365797a75ccae4ceaf266bd7834f20c4e06eaa","raw":{"aspect":"P","body_system":"endocrine","disease_id":"OMIM:151660","disease_name":"Lipodystrophy, familial partial, type 2","evidence":"PCS","frequency_raw":"4/6","hpo_id":"HP:0000842","is_excluded":false,"label":"Hyperinsulinemia","onset_id":null,"reference":"PMID:37303127","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"cd368faed76aa9854e465b8c4cd82ab8f765263688980ca5f5c116d97c658b3e","raw":{"aspect":"P","body_system":"other","disease_id":"ORPHA:2348","disease_name":"Familial partial lipodystrophy, Dunnigan type","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0003326","is_excluded":false,"label":"Myalgia","onset_id":null,"reference":"ORPHA:2348","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"cea990e189119fbf0672289340129d2bdbf319461ca5cc6e7048aeb26b55832f","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:151660","disease_name":"Lipodystrophy, familial partial, type 2","evidence":"PCS","frequency_raw":"0/6","hpo_id":"HP:0012100","is_excluded":true,"label":"Abnormal circulating creatinine concentration","onset_id":null,"reference":"PMID:37303127","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"d40cd19681db7b325e8a2f010aa2a108dce8ef305411c45f8f35bd163b75bfbb","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:2348","disease_name":"Familial partial lipodystrophy, Dunnigan type","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0009125","is_excluded":false,"label":"Lipodystrophy","onset_id":null,"reference":"ORPHA:2348","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d4d0fc35c13ba99aeb7c9be7710ec305f746e6f6e5cc6959505337d7794042a9","raw":{"aspect":"P","body_system":"digestive","disease_id":"OMIM:151660","disease_name":"Lipodystrophy, familial partial, type 2","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001735","is_excluded":false,"label":"Acute pancreatitis","onset_id":null,"reference":"OMIM:151660","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"d731efd7f1f30dc71d32cad8095b3c8787bb368b48fbd7414a6e3246c36d2c62","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:2348","disease_name":"Familial partial lipodystrophy, Dunnigan type","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000855","is_excluded":false,"label":"Insulin resistance","onset_id":null,"reference":"ORPHA:2348","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d95f6e8c4235cead8be89539071f7f80f496545319739f8f1c967bb47430a170","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:2348","disease_name":"Familial partial lipodystrophy, Dunnigan type","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0006824","is_excluded":false,"label":"Cranial nerve paralysis","onset_id":null,"reference":"ORPHA:2348","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"d9f4c1e270d7763f279a75d906139130b1baf1af8d7ff1fdef7058191f7b2443","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:151660","disease_name":"Lipodystrophy, familial partial, type 2","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0012185","is_excluded":false,"label":"Constrictive median neuropathy","onset_id":null,"reference":"PMID:11344241","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"da5036c9e20123b648722c791253cdc2ca578d52cef9f2de5c9bb07c091de32f","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:151660","disease_name":"Lipodystrophy, familial partial, type 2","evidence":"PCS","frequency_raw":"2/118","hpo_id":"HP:0001678","is_excluded":false,"label":"Atrioventricular block","onset_id":null,"reference":"PMID:37843397;PMID:17250669","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"e15bfbdcbc17c2cf5aaca695b745457e23e131960a99de6575221dac3e3b9eb8","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:151660","disease_name":"Lipodystrophy, familial partial, type 2","evidence":"PCS","frequency_raw":"55/125","hpo_id":"HP:0003124","is_excluded":false,"label":"Hypercholesterolemia","onset_id":null,"reference":"PMID:37843397;PMID:28450900;PMID:37303127;PMID:17250669","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"e273bc45e113d27b93fbd545d31d470e65aa09b2ce051fd1594aa309e97a580a","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:151660","disease_name":"Lipodystrophy, familial partial, type 2","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0003758","is_excluded":false,"label":"Reduced subcutaneous adipose tissue","onset_id":null,"reference":"OMIM:151660","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"e2b312c361d132f7cd97ea90dd121c7996da76f3c8c108097bd329cf950c9092","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:151660","disease_name":"Lipodystrophy, familial partial, type 2","evidence":"PCS","frequency_raw":"6/9","hpo_id":"HP:0009064","is_excluded":false,"label":"Generalized lipodystrophy","onset_id":null,"reference":"PMID:37843397;PMID:37303127;PMID:11344241","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"e5051312f6b639f9bc52fa7326ea42f9d10df424b4f5a699a86665e3b8cbc131","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:2348","disease_name":"Familial partial lipodystrophy, Dunnigan type","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001733","is_excluded":false,"label":"Pancreatitis","onset_id":null,"reference":"ORPHA:2348","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"ee008dd5c01fb25336eca24cdf1540ba8e114b7131668956a3f6ae5b5dfb1ff4","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:151660","disease_name":"Lipodystrophy, familial partial, type 2","evidence":"PCS","frequency_raw":"108/115","hpo_id":"HP:0009002","is_excluded":false,"label":"Loss of truncal subcutaneous adipose tissue","onset_id":null,"reference":"PMID:37843397","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"f027052f96b5f7de323b4f9d4dc93aecde1df00eda11b6c1e3c91941419c12f4","raw":{"aspect":"P","body_system":"other","disease_id":"ORPHA:2348","disease_name":"Familial partial lipodystrophy, Dunnigan type","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0100607","is_excluded":false,"label":"Dysmenorrhea","onset_id":null,"reference":"ORPHA:2348","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f704a89efc3be613b5caf735048c66b7a6bc5523b062d32086a9c1a4b6a97e52","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:2348","disease_name":"Familial partial lipodystrophy, Dunnigan type","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000991","is_excluded":false,"label":"Xanthomatosis","onset_id":null,"reference":"ORPHA:2348","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"f8e5a557d1ac25f297b3efc773febcddb3f8b5f2db505bf38323619385d06c57","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:151660","disease_name":"Lipodystrophy, familial partial, type 2","evidence":"PCS","frequency_raw":"87/108","hpo_id":"HP:0001397","is_excluded":false,"label":"Hepatic steatosis","onset_id":null,"reference":"PMID:37843397;PMID:37303127","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"fc5248c29650ec06d42d81b055dcf3f94ffa48381a5987ad53558b775d1c97c4","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:2348","disease_name":"Familial partial lipodystrophy, Dunnigan type","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0100658","is_excluded":false,"label":"Cellulitis","onset_id":null,"reference":"ORPHA:2348","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"fd73b92c152db78ec98da46f00a8bef73b06009a9a364e7e28562b529b9b7835","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:151660","disease_name":"Lipodystrophy, familial partial, type 2","evidence":"PCS","frequency_raw":"3/5","hpo_id":"HP:0031185","is_excluded":false,"label":"Elevated circulating NT-proBNP concentration","onset_id":null,"reference":"PMID:37303127","source_release":"2026-06-23"},"sourceGroups":["published"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/3126\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0007906\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>GARD:0003126</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Familial partial lipodystrophy, Dunnigan type (FPLD2) is a rare, genetic disorder that affects the amount and distribution of fat (adipose tissue) in the body. Symptoms typically develop around puberty, after having normal adipose tissue in childhood. FPLD2 causes a loss of adipose tissue from the limbs, torso, buttocks and hips, while causing a buildup of adipose tissue in the face, neck, and upper back. It may also cause increased musculature. Some people with FPLD2 have areas of dark, thick skin (acanthosis nigricans), and females may have excessive hairiness (hirsutism) and menstrual abnormalities. Metabolic abnormalities develop in adolescence or adulthood, leading to signs and symptoms that may include insulin resistance, dyslipidemia, diabetes, pancreatitis (or recurrent acute pancreatitis), liver steatosis, atherosclerosis, and an increased risk of heart disease. FPLD2 is caused by genetic changes in the LMNA gene and inheritance is autosomal dominant.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/3126\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"familial-partial-lipodystrophy-dunnigan-type","sourceDocuments":[{"name":"GARD: Familial partial lipodystrophy, Dunnigan type","reviewed":null,"source_release":"2026-10-25T03:38:56Z","url":"https://rarediseases.info.nih.gov/diseases/3126"},{"name":"MONDO: familial partial lipodystrophy, Dunnigan type","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0007906"}],"sourceNote":"","synonyms":["Dunnigan syndrome","familial partial lipodystrophy type 2","FPL2","FPLD2","lipodystrophy, familial partial, type 2"],"takeawayHtml":"","title":"familial partial lipodystrophy, Dunnigan type"},"schemaVersion":1}
